NCT05184829View on ClinicalTrials.gov

A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1

NANot yet recruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
ProgressionPostoperative Recovery
Interventions
OTHER

selective lymph node dissection

selective lymph node dissection

OTHER

Systemic Lymph Node Dissection

Systemic Lymph Node Dissection

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER

NCT05184829 - A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1 | Biotech Hunter | Biotech Hunter